ClinicalTrials.Veeva

Menu

Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation Time

University of New Mexico (UNM) logo

University of New Mexico (UNM)

Status

Completed

Conditions

Orientation
Post-anesthesia Recovery

Treatments

Drug: Ketamine
Drug: Methohexital

Study type

Interventional

Funder types

Other

Identifiers

NCT01567852
HRRC#: 11-236

Details and patient eligibility

About

When undergoing ECT treatments, patient recovery time and re-orientation time may be shorter using ketamine for induction than using methohexital.

Full description

ECT treatments are done under general anesthesia, and the induction is commonly done with methohexital. We will study whether using ketamine as an induction agent will result in a faster recovery time and quicker re-orientation time compared to using methohexital.

Enrollment

20 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients eligible for ECT with a primary mood disorder (bipolar disorder, major depressive disorder) will be eligible to participate in this study. - Patients must have decisional capacity and must be able to consent for this study.

Exclusion criteria

  • patients with a primary psychotic disorder (schizophrenia, schizoaffective disorder); patients designated as having an American Society of Anesthesiologist (ASA) Status of greater than 3;
  • patients with a known allergic reactions to methohexital , ketamine and succinylcholine;
  • patients with current or previous history of aneurysms, intracranial bleeds, or intracranial hypertension;
  • patients with uncontrolled severe hypertension.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

20 participants in 2 patient groups

Ketamine First
Experimental group
Description:
This arm will receive ketamine for induction first, followed by alternating treatments between methohexital and ketamine
Treatment:
Drug: Ketamine
Drug: Methohexital
Methohexital First
Experimental group
Description:
This arm will receive Methohexital first for induction, followed by alternating treatments between ketamine and methohexital.
Treatment:
Drug: Ketamine
Drug: Methohexital

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems